Pia Baumann

Pia Baumann has a diverse and extensive work experience in the medical field. Pia currently holds the position of Chief Medical Officer at Medivir AB, starting in February 2023. Prior to this, Pia worked as the VP Global Medical Franchise Head Tagrisso-TDR at AstraZeneca from July 2020 to February 2023. Pia also served as the VP Global Medical Affairs Lead Solid Tumors at Takeda Oncology from September 2018 to July 2020. Before that, Pia worked as the Senior Director Global Medical Affairs at Incyte from April 2017 to September 2018. Pia also held multiple roles at ARIAD Pharmaceuticals, Inc., including Global Medical Affairs Lung Cancer Lead from September 2015 to April 2017, and Medical Director Nordics from September 2013 to December 2015. Prior to that, Pia was the Disease Area Head Hematology European Market at Bristol-Myers Squibb from June 2012 to September 2013. Pia also worked as a Regional Scientific Advisor Oncology/Hematology INCA at Bristol-Myers Squibb, Princeton, New Jersey from August 2011 to May 2012. Pia started their career as a Nordic Medical Advisor Oncology/Hematology at Genzyme in 2010. Pia began their medical journey as an MD PhD Oncologist at Karolinska University Hospital in 1999 and remained there until 2010.

Pia Baumann completed their education at Karolinska Institutet, where they earned a Doctor of Medicine (MD) degree in the field of Medicine. The exact timeframe for this degree is not provided. However, starting in 2004 and ending in 2009, Pia Baumann pursued a PhD in Oncology at the same institution.